Clinical Trials



The AKTN is an investigator- led collaborative research group set up by Kidney Health Australia (KHA) and the Australian and New Zealand Society of Nephrology (ANZSN) in 2004. The Network’s Operations Secretariat comprises a core group of Nephrologists, Project Managers, Clinical Research Associates, Statisticians, Data Managers, and Clinical Trialists, and is guided by an Advisory Board and a Scientific Committee. The AKTN is under the umbrella of the Centre for Kidney Disease Research, School of Medicine, The University of Queensland.

The Network’s mission is the delivery of high quality clinical trials to improve the health and wellbeing of people with kidney disease. The AKTN is involved in all aspects of clinical trial conduct, and aims to work in conjunction with the kidney care community to achieve world class, innovative solutions that make meaningful differences to people with kidney disease. The AKTN is also committed to fostering clinical trials expertise within the Nephrological community of Australia, New Zealand and the Asia-Pacific region by offering formal and informal educational and training opportunities.

There are currently 63 renal units participating in AKTN trials; these are based in all states and territories of Australia, in New Zealand, Malaysia, China, the United Kingdom, Canada and Mexico. Additionally, the AKTN partners with organisations throughout the world to collaborate on multi-national clinical trials designed to have a significant impact on the global kidney care and patient community.